TY - JOUR
T1 - Establishment of a Neurodegenerative Charcot Mouse Model
AU - Koroneos, Zachary A.
AU - Ptasinski, Anna
AU - Stauch, Christopher
AU - King, Tonya S.
AU - Fanburg-Smith, Julie C.
AU - Aynardi, Michael
N1 - Publisher Copyright:
© The Author(s) 2023.
PY - 2023/12
Y1 - 2023/12
N2 - Background: This study aimed to mimic the changes from Charcot neuropathic arthropathy in humans by examining the effects of exposing diet-induced obese (DIO) mice to neurotrauma through a regimented running protocol. Methods: Forty-eight male wild-type C57BL/6J mice were obtained at age 6 weeks and separated into 2 groups for diet assignment. After a 1-week acclimation period, half of the mice consumed a high-fat diet (60% fat by kcal) ad libitum to facilitate neuropathic diet-induced obesity whereas the other half were control mice and consumed an age-matched standard low-fat control diet (10% fat by kcal). At age 12 weeks, half of the animals from each group were subjected to a high-intensity inclined treadmill running protocol, which has been previously demonstrated to induce neurotrauma. Sensory testing and radiographic analyses were periodically performed. Histopathologic analyses were performed post killing. Results: DIO mice had significantly higher bodyweights, higher body fat percentages, and lower bone mineral density than wildtype control mice that were fed a normal diet throughout the experiment (P <.001 for each). DIO mice displayed significantly reduced sensory function in week 1 (P =.005) and this worsened over time, requiring 20.6% more force for paw withdrawal by week 10 (P <.001). DIO mice that ran demonstrated greater midfoot subluxation and tarsal instability over all time points compared with normal-diet mice that ran (P <.001). Histopathologic analyses revealed that DIO mice that ran demonstrated significant changes compared with controls that ran (P <.001 for each parameter). Conclusion: Changes akin to the earliest changes observed in or before joint destruction identified in diabetic Charcot neuropathic arthropathy in humans were observed. Clinical Relevance: There is currently no standard of treatment for patients with Charcot neuropathic arthropathy. This study establishes a protocol for an animal model that can be used to study and compare interventions to treat this disease.
AB - Background: This study aimed to mimic the changes from Charcot neuropathic arthropathy in humans by examining the effects of exposing diet-induced obese (DIO) mice to neurotrauma through a regimented running protocol. Methods: Forty-eight male wild-type C57BL/6J mice were obtained at age 6 weeks and separated into 2 groups for diet assignment. After a 1-week acclimation period, half of the mice consumed a high-fat diet (60% fat by kcal) ad libitum to facilitate neuropathic diet-induced obesity whereas the other half were control mice and consumed an age-matched standard low-fat control diet (10% fat by kcal). At age 12 weeks, half of the animals from each group were subjected to a high-intensity inclined treadmill running protocol, which has been previously demonstrated to induce neurotrauma. Sensory testing and radiographic analyses were periodically performed. Histopathologic analyses were performed post killing. Results: DIO mice had significantly higher bodyweights, higher body fat percentages, and lower bone mineral density than wildtype control mice that were fed a normal diet throughout the experiment (P <.001 for each). DIO mice displayed significantly reduced sensory function in week 1 (P =.005) and this worsened over time, requiring 20.6% more force for paw withdrawal by week 10 (P <.001). DIO mice that ran demonstrated greater midfoot subluxation and tarsal instability over all time points compared with normal-diet mice that ran (P <.001). Histopathologic analyses revealed that DIO mice that ran demonstrated significant changes compared with controls that ran (P <.001 for each parameter). Conclusion: Changes akin to the earliest changes observed in or before joint destruction identified in diabetic Charcot neuropathic arthropathy in humans were observed. Clinical Relevance: There is currently no standard of treatment for patients with Charcot neuropathic arthropathy. This study establishes a protocol for an animal model that can be used to study and compare interventions to treat this disease.
UR - http://www.scopus.com/inward/record.url?scp=85173677953&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85173677953&partnerID=8YFLogxK
U2 - 10.1177/10711007231198822
DO - 10.1177/10711007231198822
M3 - Article
C2 - 37818993
AN - SCOPUS:85173677953
SN - 1071-1007
VL - 44
SP - 1278
EP - 1286
JO - Foot and Ankle International
JF - Foot and Ankle International
IS - 12
ER -